granulocyte macrophage colony stimulation factor
Showing 1 - 25 of >10,000
Ependymoma, Recurrent Childhood, Ependymoma Trial in Denver, Orlando (Granulocyte Macrophage Colony Stimulation Factor)
Active, not recruiting
- Ependymoma, Recurrent Childhood
- Ependymoma
- Granulocyte Macrophage Colony Stimulation Factor
-
Denver, Colorado
- +1 more
Feb 8, 2022
Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)
Recruiting
- Neuroblastoma Recurrent
- Natural killer cell
- +4 more
-
Hong Kong, Hong KongHong Kong Children's Hospital
Feb 22, 2023
Neuroblastoma Trial in New York (Hu3F8 With GM-CSF)
Active, not recruiting
- Neuroblastoma
- Hu3F8 With GM-CSF
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 2, 2022
Recurrent Osteosarcoma Trial in Los Angeles, New York, Houston (humanized anti-GD2 antibody, GM-CSF)
Recruiting
- Recurrent Osteosarcoma
- humanized anti-GD2 antibody
- GM-CSF
-
Los Angeles, California
- +2 more
Dec 22, 2022
Breast Cancer Trial in Boston (Autologous, Lethally Irradiated Breast Cancer Cells)
Completed
- Breast Cancer
- Autologous, Lethally Irradiated Breast Cancer Cells
-
Boston, Massachusetts
- +1 more
Mar 30, 2022
Primary Ovarian Insufficiency, Premature Ovarian Failure Trial in Toronto (Neupogen)
Recruiting
- Primary Ovarian Insufficiency
- Premature Ovarian Failure
-
Toronto, Ontario, CanadaTrio Fertility
Oct 31, 2023
Renal Cancer Trial in Boston (Dendritic Cell Tumor Fusion Vaccine, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF))
Active, not recruiting
- Renal Cancer
- Dendritic Cell Tumor Fusion Vaccine
- Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 2, 2023
Thymoma Trial in Shanghai (Radiotherapy Combined with GM-CSF)
Recruiting
- Thymoma
- Radiotherapy Combined with GM-CSF
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 2, 2022
Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)
Recruiting
- Neuroblastoma
- Naxitamab monotherapy
- +6 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 31, 2023
Early-stage Breast Cancer Trial in Ottawa (Granulocyte Colony-Stimulating Factor (G-CSF), Omission of Granulocyte
Not yet recruiting
- Early-stage Breast Cancer
- Granulocyte Colony-Stimulating Factor (G-CSF)
- Omission of Granulocyte Colony-Stimulating Factor (G-CSF)
-
Ottawa, Ontario, CanadaThe Ottawa Hospital Cancer Centre
Feb 22, 2023
Alcoholic Hepatitis Trial in Chandigarh (Standard Medical Therapy, G-CSF, G-CSF and NAC)
Completed
- Alcoholic Hepatitis
- Standard Medical Therapy
- +2 more
-
Chandigarh, IndiaDept of Hepatology, PGIMER
Apr 29, 2023
Intrauterine Infusion of GCSF and Reproductive Outcomes in
Recruiting
- Recurrent Implantation Failure
- +2 more
- Granulocyte Colony-Stimulating Factor
- placebo
-
Cairo, AlQuahira, EgyptCairo university Kasr Alainy OBGYN hospital
Jun 8, 2022
Granulocyte Colony-stimulating Factor, Stem Cell Mobilization Trial (PEG-rhG-CSF)
Not yet recruiting
- Granulocyte Colony-stimulating Factor
- Stem Cell Mobilization
- (no location specified)
Jun 13, 2022
Pancreatic Cancer Trial in Chongqing (OH2 injection)
Recruiting
- Pancreatic Cancer
- OH2 injection
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Jan 27, 2022
HIV, Cytopenias Trial in Buffalo (Zidovudine, Sargramostim)
Completed
- HIV Infections
- Cytopenias
-
Buffalo, New YorkSUNY / Erie County Med Ctr at Buffalo
Oct 27, 2021
Hepatitis B, Chronic Trial in Beijing (Granulocyte Macrophage-colony Stimulating Factor, Entecavir)
Terminated
- Hepatitis B, Chronic
- Granulocyte Macrophage-colony Stimulating Factor
- Entecavir
-
Beijing, Beijing, China302 Military Hospital
Mar 9, 2022
Pediatric Cancer, Neutropenia, Lenograstim Trial in Taoyuan (G-CSF administration (bolus injection versus intravenous infusion))
Recruiting
- Pediatric Cancer
- +4 more
- G-CSF administration (bolus injection versus intravenous infusion)
-
Taoyuan, ROC, TaiwanChang Gung Children Hospital
Nov 21, 2023
Breast Ductal Carcinoma In Situ Trial in Jacksonville, Rochester (Granulocyte-Macrophage Colony-Stimulating Factor,
Recruiting
- Breast Ductal Carcinoma In Situ
- Granulocyte-Macrophage Colony-Stimulating Factor
- +2 more
-
Jacksonville, Florida
- +1 more
Dec 10, 2021
Advanced Ovarian Cancer Trial in Seattle (AST-201, Paclitaxel, Carboplatin)
Not yet recruiting
- Advanced Ovarian Cancer
- AST-201
- +4 more
-
Seattle, WashingtonUniversity of Washington
Mar 20, 2023
Lymphoma, Non-Hodgkin, HIV Trial in Los Angeles (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)
Completed
- Lymphoma, Non-Hodgkin
- HIV Infections
- Bleomycin sulfate
- +8 more
-
Los Angeles, CaliforniaUSC CRS
Oct 26, 2021
Sarcoma, Kaposi, HIV Trial in New York (Interferon alfa-2b, Zidovudine, Sargramostim)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Interferon alfa-2b
- +2 more
-
New York, New YorkMem Sloan - Kettering Cancer Ctr
Oct 26, 2021
Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy)
Not yet recruiting
- Acute Myeloid Leukemia
- Myeloid Neoplasm
- Biospecimen Collection
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 5, 2023
Secondary Acute Myeloid Leukemia Trial in Ann Arbor (Venetoclax, FLAG Protocol)
Not yet recruiting
- Secondary Acute Myeloid Leukemia
- Venetoclax
- FLAG Protocol
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Mar 22, 2023